financetom
Business
financetom
/
Business
/
Marriott cuts 2024 revenue forecast on weakening domestic tourism in the US
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Marriott cuts 2024 revenue forecast on weakening domestic tourism in the US
Jul 31, 2024 4:46 AM

(Reuters) -Hotel operator Marriott International ( MAR ) lowered its forecast for 2024 room revenue growth on Wednesday, as the domestic travel industry in the U.S. continues to perform poorly.

Shares of the company were down 4.7% before the bell.

Marriott ( MAR ) expects revenue per available room (RevPAR) to grow between 3% and 4% this year, compared to the 3% to 5% growth it had previously forecast.

Domestic travel in the U.S. has been weak since the start of the year as more tourists are choosing to travel internationally to destinations in Asia, Latin America and Europe.

The company said it was also impacted by a weaker operating environment in Greater China.

Total revenue for the quarter through June 30 was $6.44 billion, up about 6% from a year earlier.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Broadcom forecasts first-quarter revenue above estimates on strong AI chip demand
Broadcom forecasts first-quarter revenue above estimates on strong AI chip demand
Dec 12, 2024
Dec 12 (Reuters) - Broadcom ( AVGO ) forecast its first-quarter revenue above Wall Street estimates on Thursday, betting on booming demand for its custom artificial intelligence chips and networking gear from cloud providers doubling down on GenAI infrastructure adoption. Shares of the Palo Alto, California-based company rose over 3% in extended trading, having gained about 60% so far this...
Chimera Investment Insider Bought Shares Worth $998,580, According to a Recent SEC Filing
Chimera Investment Insider Bought Shares Worth $998,580, According to a Recent SEC Filing
Dec 12, 2024
04:39 PM EST, 12/12/2024 (MT Newswires) -- Jack Lee Macdowell Jr, Chief Investment Officer, on December 10, 2024, executed a purchase for 66,000 shares in Chimera Investment ( CIM/PA ) for $998,580. Following the Form 4 filing with the SEC, Macdowell has control over a total of 166,000 shares of the company, with 166,000 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1409493/000162828024051052/xslF345X05/wk-form4_1734039101.xml...
Ascendis Pharma's Supplemental BLA for Adult Growth Hormone Deficiency Drug Accepted by FDA
Ascendis Pharma's Supplemental BLA for Adult Growth Hormone Deficiency Drug Accepted by FDA
Dec 12, 2024
04:42 PM EST, 12/12/2024 (MT Newswires) -- Ascendis Pharma ( ASND ) said its supplemental biologics license application for TransCon hGH as therapy for adult growth hormone deficiency was accepted for review by the US Food and Drug Administration. The FDA has set a July 27 review deadline, the company said Thursday in a statement. The supplemental application is based...
Arcosa Renews $50 Million Share Buyback Program; Dividend Maintained
Arcosa Renews $50 Million Share Buyback Program; Dividend Maintained
Dec 12, 2024
04:44 PM EST, 12/12/2024 (MT Newswires) -- Arcosa ( ACA ) said late Thursday it renewed its $50 million share buyback plan, effective Jan. 1, 2025, through Dec. 31, 2026. The latest plan replaces the one with the same amount that will expire on Dec. 31, the company said. The company also said it kept its quarterly dividend at $0.05...
Copyright 2023-2026 - www.financetom.com All Rights Reserved